56 Biggest Movers From Yesterday

Gainers

• American Electric Technologies, Inc AETI shares climbed 169.93 percent to close at $1.08 on Monday after the company disclosed that its joint venture, BOMAY, received a major order for drilling rig control systems.
• TESARO Inc TSRO gained 58.47 percent to close at $73.50 after GlaxoSmithKline plc GSK announced plans to acquire the company for $75 per share in cash.
• Global Blood Therapeutics, Inc. GBT shares climbed 47.81 percent to close at $46.62. Global Blood announced Monday that the FDA has agreed to allow filing for its late-stage sickle cell disease, or SCD, candidate Voxelotor under an accelerated approval pathway. The company said it would submit a new drug application, or NDA, for the pipeline asset under the pathway.
• Guardant Health, Inc. GH gained 28.58 percent to close at $45.94.
• Lilis Energy, Inc. LLEX rose 27.67 percent to close at $2.63.
• Vanda Pharmaceuticals Inc. VNDA shares rose 25.68 percent to close at $31.47 after the company's phase 2 study of Tradipitant met its primary endpoint and most secondary endpoints.
• Biohaven Pharmaceutical Holding Company Ltd. BHVN rose 25.39 percent to close at $42.62 after reporting positive Phase 3 results with rimegepant zydis orally dissolving tablet for the acute treatment of migraine.
• Apellis Pharmaceuticals, Inc. APLS gained 17.73 percent to close at $18.06 after presents updated data from ongoing APL-2 Phase 2 clinical study at the ASH 2018.
• Laredo Petroleum, Inc. LPI climbed 17.39 percent to close at $5.13.
• Provention Bio, Inc. PRVB gained 16.88 percent to close at $2.70.
• Elastic N.V. ESTC climbed 14.77 percent to close at $82.00.
• Aeterna Zentaris Inc. AEZS gained 14.5 percent to close at $3.87.
• SI-BONE, Inc. SIBN surged 13.81 percent to close at $20.44.
• argenx SE ARGX rose 13.49 percent to close at $109.82 after Janssen affiliate Cilag GmbH International disclosed a worldwide collaboration and license agreement with Argenx for cancer immunotherapy cusatuzumab.
• Cenovus Energy Inc. CVE shares jumped 12.87 percent to close at $8.33.
• SG Blocks, Inc. SGBX jumped 12.54 percent to close at $3.68 after receiving a $25 million purchase order from Phoenix Hotel & Hospitality.
• Vapotherm, Inc. VAPO gained 12.29 percent to close at $20.65.
• Arcus Biosciences, Inc. RCUS rose 12.17 percent to close at $12.81.
• Osmotica Pharmaceuticals plc OSMT climbed 12.06 percent to close at $8.83.
• Seadrill Limited SDRL shares rose 11.96 percent to close at $15.26 after dropping 7.40 percent on Friday.
• Tribune Media Company TRCO rose 11.72 percent to close at $44.98 after Nexstar Media Group Inc NXST announced plans to acquire the company for $46.50 per share.
• Crescent Point Energy Corp. CPG gained 11.49 percent to close at $3.30.
• Forterra, Inc. FRTA jumped 11.43 percent to close at $5.46.
• Advanced Micro Devices, Inc. AMD gained 11.31 percent to close at $23.71.
• Clovis Oncology, Inc. CLVS rose 10.87 percent to close at $19.08.
• ZAGG Inc ZAGG gained 9.95 percent to close at $11.05.
• Wynn Resorts, Limited WYNN rose 9.5 percent to close at $119.79.
• New Age Beverages Corporation NBEV rose 9.07 percent to close at $5.05 after the company announced plans to acquire Morinda Holdings, Inc. for $75 million in cash and $10 million in stock.
• RadiSys Corporation RSYS rose 6.83 percent to close at $1.72 after the company reported the CFIUS clearance related to its acquisition of Reliance Industries.
• Chart Industries, Inc. GTLS rose 6.75 percent to close at $67.85. Evercore ISI Group upgraded Chart Industries from In-Line to Outperform.
• CASI Pharmaceuticals, Inc. CASI gained 5.31 percent to close at $4.56 after reporting China market approval of Melphalan Hydrochloride for injection.

Losers

• Sienna Biopharmaceuticals, Inc. SNNA shares dipped 37.59 percent to close at $6.31 on Monday after reporting top-line results from a Phase 2b study of SNA-120.
• Hexindai Inc. HX shares dropped 27.73 percent to close at $3.18 following Q2 results. Hexindai posted a Q2 loss of $0.36 per share on sales of $3.62 million.
• Adial Pharmaceuticals, Inc. ADIL fell 26.3 percent to close at $2.83 on Monday after rising 37.14 percent on Friday.
• Borqs Technologies, Inc. BRQS dropped 23.77 percent to close at $4.345 on Monday.
• Aphria Inc. APHA declined 23.42 percent to close at $6.05 after Reuters reported that 2 research firms issued negative reports on the stock.
• Arlo Technologies, Inc. ARLO shares declined 22.86 percent to close at $9.28. Arlo Technologies expects Q4 sales of $125 million to $130 million.
• Tonix Pharmaceuticals Holding Corp. TNXP shares fell 22.16 percent to close at $4.04 after dropping 25.54 percent on Friday.
• Tel-Instrument Electronics Corp. TIK fell 20.16 percent to close at $3.09 after surging 57.96 percent on Friday.
• Realm Therapeutics Plc RLM shares tumbled 17.79 percent to close at $2.45.
• Sphere 3D Corp. ANY dropped 17.49 percent to close at $4.34.
• Kodiak Sciences Inc. KOD dipped 14.05 percent to close at $7.95.
• Ocular Therapeutix, Inc. OCUL dropped 13.96 percent to close at $5.73. Cantor Fitzgerald reiterated Overweight rating on Ocular Therapeutics following the FDA approval of DEXTENZA.
• Agios Pharmaceuticals, Inc. AGIO fell 13.66 percent to close at $56.81 after presenting updated data from the ivosidenib Phase 1 dose-escalation and expansion trial in IDH1 mutant positive patients with newly diagnosed acute myeloid leukemia ineligible for standard treatment and myelodysplastic syndrome.
• StoneMor Partners L.P. STON dropped 13.14 percent to close at $3.04.
• Arsanis, Inc. ASNS tumbled 13.11 percent to close at $3.38.
• Alliqua BioMedical, Inc. ALQA shares dipped 13.04 percent to close at $2.40.
• UTStarcom Holdings Corp. UTSI shares declined 12.61 percent to close at $3.12.
• Trillium Therapeutics Inc. TRIL fell 12.29 percent to close at $2.64 following an update on its intratumoral TTI-621 program at the American Society of Hematology 60th Annual Meeting.
• Xcel Brands, Inc. XELB fell 10.63 percent to close at $1.85.
• Gamida Cell Ltd. GMDA dropped 10.38 percent to close at $13.81.
• Aptinyx Inc. APTX fell 10 percent to close at $19.99. Aptinyx achieved its primary endpoint in the study of NYX-2925.
• Arvinas Holding Company, LLC ARVN dropped 9.58 percent to close at $15.29.
• Xenetic Biosciences, Inc. XBIO dipped 7.58 percent to close at $3.05.
• Magenta Therapeutics, Inc. MGTA dropped 6.13 percent to close at $9.18.
• bluebird bio, Inc. BLUE fell 5.2 percent to close at $116.50. bluebird bio and Celgene Corporation CELG presented initial Phase 1 data for multiple myeloma treatment candidate bb21217 at ASH 2018.